Since its discovery in the 1990s, programmed cell death protein 1 (PD-1) has been regarded as a leading target in cancer ...

Protein powder often used as a supplement are consumed in a widespread manner, here's all you need to know about it ...

AI hallucinations have been the bane of every generative AI company, but after major scientific breakthroughs, an increasing chorus of scholars are rooting for it, finds Satyen K. Bordoloi. In the ...

U.S. food ingredient company, has submitted a Generally Recognized as Safe (GRAS) notification to the U.S. Food and Drug ...

By adapting artificial intelligence models known as large language models, researchers have made great progress in their ...

A new study has identified one of the reasons why cancer frequently spreads from elsewhere in the body to the lungs: an amino ...

If you struggle to grow your hair out or with hair loss, trust me, you're not alone. Finding the right tools for your ...

Denileukin diftitox is under clinical development by Citius Oncology and currently in Phase II for Melanoma. According to GlobalData, Phase II drugs for Melanoma have a 27% phase transition success ...

Denileukin diftitox is under clinical development by Citius Oncology and currently in Phase II for Endometrial Cancer.

“Maybe generative AI isn't just going to create beautiful cartoons and limericks to entertain ourselves and one another, and ...